Literature DB >> 1341236

Alcohol injection: a treatment for ruptured hepatocellular carcinoma.

G T Sunderland1, E M Chisholm, W Y Lau, S C Chung, W T Leung, A K Li.   

Abstract

Nine patients with bleeding from a ruptured hepatocellular carcinoma had absolute alcohol injection. Laparotomy and alcohol injection stopped the bleeding in seven patients. Injection under laparoscopic visualization was attempted in two patients and in one patient haemostatis was achieved initially. He rebled, however, 4 h later and laparotomy failed to control the bleeding. He died 2 days later because of coagulopathy and renal failure. In the second patient, bleeding was not controlled laparoscopically and immediate laparotomy and alcohol injection stopped the bleeding. The eight patients who survived left hospital between 8 and 21 days after surgery (median 10 days). In our experience, laparotomy and alcohol injection achieved good results in bleeding hepatocellular carcinoma.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1341236     DOI: 10.1016/0960-7404(92)90057-r

Source DB:  PubMed          Journal:  Surg Oncol        ISSN: 0960-7404            Impact factor:   3.279


  3 in total

1.  Outcomes and Prognostic Factors of Spontaneously Ruptured Hepatocellular Carcinoma.

Authors:  Wei Zhang; Zhi-Wei Zhang; Bi-Xiang Zhang; Zhi-Yong Huang; Wan-Guang Zhang; Hui-Fang Liang; Xiao-Ping Chen
Journal:  J Gastrointest Surg       Date:  2018-09-04       Impact factor: 3.452

2.  Liver radiofrequency ablation as emergency treatment for a ruptured hepatocellular carcinoma: a case report.

Authors:  Alessandra Bertacco; Francesco D'Amico; Maurizio Romano; Michele Finotti; Alessandro Vitale; Umberto Cillo
Journal:  J Med Case Rep       Date:  2017-03-01

3.  Safety and efficacy of dehydrated ethanol soaking of the operative field in the treatment of spontaneous hepatocellular carcinoma rupture.

Authors:  Jian Sun; Yue Zhu; Yao-Rong Peng; Wen-Bin Li; He-Yun Zhang; Zhen-Yu Zhou; Lin Wang; An-de Ma; Jie Wang
Journal:  World J Surg Oncol       Date:  2018-04-26       Impact factor: 2.754

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.